Cover Image

Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis.

Chagas disease is a neglected disease that remains a public health threat, particularly in Latin America. The most important treatment options are nitroimidazole derivatives, such as nifurtimox and benznidazole (BZN). Some studies suggest that for adults seropositive to T. cruzi but without clinical...

Full description

Saved in:

Bibliographic Details
Main Authors:	Agustín Ciapponi (Author), Fabiana Barreira (Author), Lucas Perelli (Author), Ariel Bardach (Author), Joaquim Gascón (Author), Israel Molina (Author), Carlos Morillo (Author), Nilda Prado (Author), Adelina Riarte (Author), Faustino Torrico (Author), Isabela Ribeiro (Author), Juan Carlos Villar (Author), Sergio Sosa-Estani (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2020-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study.
by: Lisandro D Colantonio, et al.
Published: (2016)

Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
by: Priscila Silva Grijó Farani, et al.
Published: (2023)

Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease.
by: Abilio Augusto Fragata-Filho, et al.
Published: (2016)

Access to benznidazole for Chagas disease in the United States-Cautious optimism?
by: Jonathan D Alpern, et al.
Published: (2017)

Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
by: Miriam Rolon, et al.
Published: (2022)

Benznidazole-Loaded Polymeric Nanoparticles for Oral Chemotherapeutic Treatment of Chagas Disease
by: Lucas Resende Dutra Sousa, et al.
Published: (2024)

A new patient registry for Chagas disease.
by: Peter Hotez, et al.
Published: (2020)

Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women.
by: Yves Carlier, et al.
Published: (2011)

Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.
by: Lívia de Figueiredo Diniz, et al.
Published: (2013)

Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole.
by: Kota Yoshioka, et al.
Published: (2020)

A new patient registry for Chagas disease
by: Peter Hotez, et al.
Published: (2020)

Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease.
by: Renata Sesti-Costa, et al.
Published: (2014)

Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study.
by: Clareci Silva Cardoso, et al.
Published: (2018)

Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
by: Marcela S Rial, et al.
Published: (2017)

Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display.
by: Luis Antonio Rodriguez Carnero, et al.
Published: (2023)

Multi-criteria decision analysis approach for strategy scale-up with application to Chagas disease management in Bolivia.
by: Maria-Jesus Pinazo, et al.
Published: (2021)

Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis.
by: Clara Crespillo-Andújar, et al.
Published: (2022)

Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment
by: Ana Lia Mazzeti, et al.
Published: (2023)

Chagas cardiomyopathy manifestations and Trypanosoma cruzi genotypes circulating in chronic Chagasic patients.
by: Juan David Ramírez, et al.
Published: (2010)

Chronic Chagas cardiomyopathy
by: Vera Demarchi Aiello, et al.
Published: (2015)

El tratamiento etiológico de la enfermedad de Chagas como estrategia de salud publica
by: Sergio Sosa, Estani
Published: (2012)

Myocardial Involvement in Chagas Disease and Insulin Resistance: A Non-Metabolic Model of Cardiomyopathy
by: Luis E. Echeverría, et al.
Published: (2020)

Population pharmacokinetics of benznidazole in neonates, infants and children using a new pediatric formulation.
by: Jaime Altcheh, et al.
Published: (2023)

Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole.
by: Claudia Magalhães Calvet, et al.
Published: (2020)

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform.
by: Maria-Jesus Pinazo, et al.
Published: (2017)

A tribute to Cecilio Romaña: Romaña's sign in Chagas disease.
by: Nathan Beucler, et al.
Published: (2020)

Chagas cardiomyopathy in the context of the chronic disease transition.
by: Alicia I Hidron, et al.
Published: (2010)

Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.
by: Jaime Altcheh, et al.
Published: (2014)

Chagas Disease Cardiomyopathy: Immunopathology and Genetics
by: Edecio Cunha-Neto, et al.
Published: (2014)

Usefulness of real-time PCR during follow-up of patients treated with Benznidazole for chronic Chagas disease: Experience in two referral centers in Barcelona.
by: Elena Sulleiro, et al.
Published: (2020)

Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
by: Elena Pérez-Antón, et al.
Published: (2018)

Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis.
by: Karina E Egüez, et al.
Published: (2017)

Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage.
by: Ana Garcia-Alvarez, et al.
Published: (2010)

Strengthening the Bolivian pharmacovigilance system: New surveillance strategies to improve care for Chagas disease and tuberculosis.
by: Nuria Cortes-Serra, et al.
Published: (2020)

A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment.
by: Elena Pérez-Antón, et al.
Published: (2021)

Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: The Bolivian Chagas network.
by: Maria-Jesus Pinazo, et al.
Published: (2022)

GWAS loci associated with Chagas cardiomyopathy influences DNA methylation levels.
by: Desiré Casares-Marfil, et al.
Published: (2021)

GWAS loci associated with Chagas cardiomyopathy influences DNA methylation levels
by: Desiré Casares-Marfil, et al.
Published: (2021)

Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: The Bolivian Chagas network
by: Maria-Jesus Pinazo, et al.
Published: (2022)

Diseño y preparación de formas farmacéuticas sólidas de benznidazol para el tratamiento de la enfermedad de Chagas
by: Sonia, Tarragona, et al.
Published: (2013)